Ukraine Adopts EU MDR-Aligned Medical Device Regulations: What Manufacturers Should Do Before 2030

On 10 June 2026, the Cabinet of Ministers of Ukraine approved two landmark resolutions — No. 758 and No. 759 — introducing new Technical Regulations for medical devices and for in vitro diagnostic (IVD) medical devices. They draw on EU medical device law: the Technical Regulation for medical devices is built on MDR (EU) 2017/745, while the one for IVD devices follows the EU IVDR approach.

These new Ukraine medical device regulations 2026 represent the country’s biggest regulatory shift in over a decade. For foreign manufacturers already selling in Ukraine — or planning to — the headline hides a critical detail that determines what you actually need to do, and when.

What changes today: nothing (almost)

Here is the point most summaries get wrong. The new Technical Regulations are applied from 31 December 2030 — “except for certain provisions.” That last phrase matters: a limited number of individual clauses may take effect earlier, which is exactly the kind of detail that trips up manufacturers relying on a quick news read.

There is also a legal distinction worth understanding. The resolution itself enters into legal force in December 2026, but the Technical Regulation it approves is put into application from 31 December 2030. Adoption and application are not the same date.

The practical takeaway for the current market:

• The 2013 regime remains fully in force — Technical Regulation No. 753 (general medical devices), No. 754 (IVD devices), and No. 755 (active implantable devices).
• Self-declaration procedures, conformity assessment routes, IFU/labelling requirements, and State Register entry all continue unchanged for now.
• Your existing declarations of conformity and registrations remain valid.

In other words: if your device is on the Ukrainian market today, you do not need to re-do anything this year. But the direction of travel is now fixed in law — and that changes how you should plan.

What the new Ukraine medical device regulations 2026 change by 2030

The new regulations replace Ukraine’s relatively light 2013 framework with the modern, risk-based EU model. Manufacturers who know MDR/IVDR will recognise the shift. Expect:

• Reclassification of many devices into higher risk classes, pulling more products into stricter conformity assessment.
• More demanding technical documentation and clinical/performance evidence, closer to an EU technical file.
• Stronger post-market surveillance and vigilance obligations.
• Enhanced traceability and identification requirements across the supply chain.
• A more formal role for the economic operators in the chain — including the Authorized Representative.

This is not a cosmetic update. It is Ukraine choosing to speak the same regulatory language as the EU — which, for compliant manufacturers, is ultimately an opportunity: documentation prepared for Europe will increasingly map onto Ukraine.

The one requirement that does not go away: the Authorized Representative

Amid all the change, one obligation is constant across both the old and the new regime — and arguably gets stronger under MDR-style rules.

If a manufacturer is not established in Ukraine, it must designate a local Authorized Representative (AR). Under the current Technical Regulations, the AR is the entity responsible for placing the device on the Ukrainian market, appearing in the State Register and on the product’s labelling and instructions for use. Under the EU MDR model that Ukraine is adopting, the Authorized Representative’s responsibilities expand: closer involvement in technical documentation, regulatory liaison, and post-market obligations.

So whichever side of 31 December 2030 you are planning for, the answer to “do we need a representative in Ukraine?” is the same: yes. The value of getting that relationship right only increases as the framework tightens.

What manufacturers should do now

The worst response to a 2030 deadline is to wait until 2030. The smart moves are available today:

1. Enter the market under the current regime. Registration and self-declaration under TR No. 753/754/755 remain straightforward relative to what is coming. Establishing your position now gives you a running start and a valid registration to build from.
2. Appoint a reliable Authorized Representative. This is required either way and is the anchor of your Ukrainian compliance. Choose a representative who understands both the 2013 rules and the incoming MDR-aligned framework.
3. Audit your technical documentation against EU MDR/IVDR expectations. If your file is already EU-ready, your transition to the 2030 requirements will be far smoother. If it is not, you have a defined window to close the gap.
4. Confirm which “certain provisions” may apply earlier. Do not assume a blanket 2030 delay for every clause — verify the specifics for your device class.

How we help

Regulatory Affairs Agency provides Authorized Representative services and full medical device registration for the Ukrainian market — under the current Technical Regulations today, and with a clear roadmap to the MDR/IVDR-aligned framework taking effect in 2030. With 10+ years supporting foreign manufacturers through Ukrainian conformity assessment, State Register entry, and AR representation, we help you make the right move now so the 2030 transition is a formality, not a fire drill.

Planning your Ukraine market entry, or want to know how the new regulations affect a device you already sell here? Get in touch — we will map your specific situation against both regimes.